Hassana El Haddaoui

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 3

Top Topics

Locally Advanced

Regulatory T Cells

Inflammatory Response

Dendritic Cells

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Casper W F van Eijck, Hassana El Haddaoui, Songul Kucukcelebi, Disha Vadgama, Amine Fellah, Dana A M Mustafa, Joachim G J V Aerts, Casper H J van Eijck, Marcella Willemsen
Rintatolimod in Advanced Pancreatic Cancer enhances Anti-Tumor Immunity through Dendritic Cell-Mediated T Cell Responses. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Casper W F van Eijck, Hassana El Haddaoui, Songul Kucukcelebi, Disha Vadgama, Amine Fellah, Dana A M Mustafa, Joachim G J V Aerts, Casper H J van Eijck, Marcella Willemsen
Rintatolimod in Advanced Pancreatic Cancer Enhances Antitumor Immunity through Dendritic Cell-Mediated T-Cell Responses. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (16) (2024)
Hassana El Haddaoui, Rianne Brood, Diba Latifi, Astrid A Oostvogels, Yarne Klaver, Miranda Moskie, Dana A M Mustafa, Reno Debets, Casper H J van Eijck
Rintatolimod (Ampligen ® ) Enhances Numbers of Peripheral B Cells and Is Associated with Longer Survival in Patients with Locally Advanced and Metastasized Pancreatic Cancer Pre-Treated with FOLFIRINOX: A Single-Center Named Patient Program. Cancers 14 (6) (2022)